Nanoemulsion as potential vehicles for transdermal delivery of pure phytopharmaceuticals and poorly soluble drug

Authors

  • Ranjit Kumar Harwansh Assistant Professor SLT Institute of Pharmaceutical Sciences, Guru Ghasidas Vishwavidyalaya (A central university), Bilaspur- 495009 (C. G.), India
  • Kartik Ch. Patra Assistant Professor SLT Institute of Pharmaceutical Sciences, Guru Ghasidas Vishwavidyalaya (A central university), Bilaspur- 495009 (C. G.), India
  • Surendra K. Pareta Assistant Professor SLT Institute of Pharmaceutical Sciences, Guru Ghasidas Vishwavidyalaya (A central university), Bilaspur- 495009 (C. G.), India

Keywords:

Transdernmal, poorly soluble drug, phytopharmaceuticals, nanoemulsion

Abstract

Nanoemulsion (NE) is defined as an O/W or W/O emulsion producing a transparent product that has a droplet size from 20-200nm and does not have the tendency to coalesce. It is promising for transdermal delivery of drugs as an efficient route of drug administration. Several mechanisms have been proposed to explain the advantages of nanoemulsions for the transdermal delivery of drugs. In transdermal delivery, the goal of dosage design is to maximize the flux through the skin into systemic circulation. A useful strategy for improving percutaneous flux is to improve the concentration of drug or choose an appropriate vehicle for the transdermal delivery. The nanoemulsions system should be a promising vehicle due to powerful ability to deliver drug through skins. With these approaches, the aim of this present study is to review the potential of nanoemulsion formulation for transdermal delivery of pure phytopharmaceuticals and poorly soluble drugs. Some nanoemulsions have however exhibited sufficiently high level of stability for them to be proposed as vehicle for drug delivery. Using the transdermal route eliminates the side effects, increases patient compliance, avoids firstpass metabolism, enhance bioavailability and maintains the plasma drug level for a longer period of time.

References

Shinoda K, Kunieda H. Phase properties

of emulsions: PIT and HLB. In: Schuster

D, ed. Encyclopedia of Emulsion

Technology New York, NY: Marcel

Dekker. 1983:337Y367.

Shafiq S, Faiyaz S, Sushma T, Ahmad FJ,

Khar RK, Ali M. Design and development

of oral oil in water ramipril nanoemulsion

formulation: in vitro and in vivo

evaluation. J Biomed Nanotech.

;3:28Y44.

Shafiq S, Faiyaz S, Sushma T, Ahmad FJ,

Khar RK, Ali M. Development and

bioavailability assessment of ramipril

nanoemulsion formulation. Eur J Pharm

Biopharm. 2007;66:227Y243.

Vladimir P, Tordilin. Nanoparticulates as

Drug Carriers: Notheastern University.

Imperial Collage Press 2006.

Amselem S, and Friedman D, Submicron

emulsion in drug targeting and delivery.

Benita S. (eds) Harwood Academic:

Amsterdam 1998.

Benita S, and Levy MY. Submicron

emulsions as colloidal drug carrier for

intravenous administration-comprehensive

physicochemical characterization. J.Pharm.

Sci. 1993;82:1069-1079

Bhargava HN, Narurkar A and Lieb

LM,Using microemulsions for drug

delivery. Pharmaceut Technol.

;11:46-54.

Osborne DW, Ward AJ, Neil KJ.

Microemulsions as topical delivery

vehicles: in-vitro transdermal studies of a

model hydrophilic drug. J Pharm

Pharmacol. 1991;43:450Y454.

Faiyaz Shakeel, Sanjula Baboota, Alka

Ahuja, Javed Ali, Mohammed Aqil And

Sheikh Shafiq1. Nanoemulsions as

Vehicles for Transdermal Delivery of

Aceclofenac. AAPS Pharm Sci Tech.

;8(4):104.

Kawakami K, Yoshikawa T, Moroto Y, et

al. Microemulsion formulation for

enhanced absorption of poorly soluble

drugs, I: prescription design. J Control

Rel. 2002;81:65Y74.

Li P, Ghosh A, Wagner RF, Krill S, Joshi

YM, Serajuddin ATM. Effect of

combined use of nonionic surfactant on

formation of oil-in-water microemulsions.

Int J Pharm. 2005;288:27Y34.

Craig DQM, Barker SA, Banning D,

Booth SW. An investigation into the

mechanisms of self-emulsification using

particle size analysis and low frequency

dielectric spectroscopy. Int J Pharm.

;114:103Y110.

Lee PJ, Langer R, Shastri VP. Novel

microemulsion enhancer formulation for

Simultaneous transdermal delivery of

hydrophilic and hydrophobic drugs.

Pharm Res. 2003; 20: 264Y269.

Warisnoicharoen W, Lansley AB,

Lawrence MJ. Light scattering

investigations on dilute non-ionic oil-inwater microemulsions. AAPS Pharm Sci

Tech [serial online]. 2002;2:E12.

Kreilgaard M, Kemme MJB, Burggraaf J,

Schoemaker RC, Cohen AF. Influence

of a microemulsion vehicle on cutaneous

bioequivalence of a lipophilic model drug

assessed by microdialysis and

pharmacodynamics. Pharm Res.

;18:593Y599.

Attwood D, Currie LRJ and Elworthy PH.

Studies of Solubilized miceller

solutions. 1. Phase studies and particlesize analysis of solution formed with

non ionic surfactants. J Coll Interf Sci.

;46:249-254.

Gasco MR, Gallarate M, Pattarino F. In

vitro permeation of azelaic acid from

viscosized microemulsions. Int J Pharm.

;69:193Y196.

Benson HAE, Transdermal Drug

Delivery: Penetration Enhancement

Techniques. Current Drug Delivery.

;2:23-33.

Kriwet K, Muller-Goymann CC.

Diclofenac release fromphospholipid drug

systems and permeation through excised

human stratum corneum. Int J Pharm.

;125:231Y242.

Flynn GL. In Percutaneous absorption,

Bronaugh, R.L Maibach, HI, Eds. Marcel

Dekker Inc. New York. 1985:17-52.

Kasting GB, Smith RL, Anderson BD. In

Prodrugs: topical and ocular drug

delivery, Sloan, K., Ed. Marcel Dekker

Inc.: New York. 1992:117-161.

Potts RO, Guy RH. Pharm. Res.

;9:663-9.

Scheuplein RJ, Blank IH, Brauner GJ,

MacFarlane DJ J. Invest Dermatol. 969;

: 63-70.

Scheuplein RJ, Blank IH. Physiol. Rev.

;51:702-747.

Elias PM, McNutt NS, Friend DS. Anat.

Rec. 1977;189:577-94.

Elias PM, Friend DS J, Cell Biol.

;65:180-191.

Nemanic MK, Elias PM, J. Histochem.

Cytochem. 1980;28:573-8.

Potts R.O, Francoeur ML J. Invest

Dermatol. 1991;96:495-9.

Bodde HE, Van den Brink I, Koerten H,

De Haan FH. J.Control Rel. 1991;15:227-

Katz M, Poulsen BJ, Brodie BB, Gilette J.

In Handbook of Experimental

Pharmacology. Eds. Springer Verlag

Berlin. 1971:103-174.

Yano T, Nakagawa A, Tsuji M, Noda K.

Life Sci., 1986;39:1043-50.

Bos JD, Meinardi MM, Exp. Dermatol.,

;9:165-9.

Barry BW, Eur. J. Pharm. Sci.,

;14:101-14.

Asbill CS, El-Kattan AF, Michniak B.

Crit. Rev. Ther. Drug Carrier Syst.,

;17:621-58.

Hadgraft J. Int. J. Pharm., 1999:184:1-6.37. Walters KA, Hadgraft J. Pharmaceutical

Skin Penetration Enhancement. Drugs and

the Pharmaceutical Sciences., New York:

Marcel Dekker Inc. 1993: Vol. 59:440.

Barry BW. Int. J. Cosmet. Sci.,

;10:281-293.

Barry BW. J. Control Rel., 1991;15:237-

Williams AC, Barry BW. Pharm. Res.,

;8:17-24.

Behl CR, Flynn GL, Kurihara T, Harper

N, Smith W, Higuchi WI, Ho NF, Pierson

CL. J. Invest. Dermatol., 1980;75:346-52.

McKenzie AW, Stoughton RB. Arch.

Dermatol., 1962;86:608-610.

Francoeur ML, Golden GM, Potts RO.

Pharm. Res., 1990;7:621-7.

Yamane MA, Williams AC, Barry BW. J.

Pharm. Pharmacol., 1995;47:978-89.

Walters K.A, Walker M, Olejnik O J.

Pharm. Pharmacol. 1988;40:525-9.

Walters KA, Hadgraft J, Guy RH. In

Transdermal drug delivery. Eds. Marcel

Dekker: New York. 1988:197-246.

Wotton PK, Mollgaard B, Hadgraft J,

Hoelgaard A. Int. J. Pharm., 1985;24:19-

Harrison JE, Watkinson AC, Green DM,

Hadgraft J, Brain K. Pharm. Res.,

;13:542-6.

Waranis RP, Siver KG, Sloan KB. Int. J.

Pharm., 1987;36:211.

Yamane MA, Williams AC, Barry BW. J.

Pharm. Pharmacol., 1995;47:978-89.

Pellett M A, Roberts MS, Hadgraft J.

Int. J. Pharm., 1997;151:91-98.

Sloan KB. Sloan KB, Topical and Ocular

Drug Delivery Ed. In Prodrugs, Marcel

Dekker: New York. 1992:179-220.

Riviere JE, Heit MC. Pharm. Res.,

;14:687-97.

Banga AK, Bose S, Ghosh TK. Int. J.

Pharm., 1999;179:1-19.

Jadoul A, Bouwstra J, Preat VV. Adv.

Drug Deliv. Rev., 1999;35:89-105.

Teichmann A, Heuschkel S, Jacobi U,

Presse G, Eubert R HH, Sterry W,

Lademann J. .Comparison of stratum

corneum penetration and localization of a

lipophilic model drug applied in an o/w

microemulsion and an amphiphilic cream.

European Journal of Pharmaceutics and

Biopharmaceutics. 2007;67:699–706.

Cui J, Yu B, Zhao Y, Zhu W, Li H, Lou

H, Zhai G. Enhancement of oral

absorption of curcumin by selfmicroemulsifying drug delivery systems.

International Journal of Pharmaceutics.

;371:148–155.

Tsai Y, Lee K, Huang Y, Huang C, Wu P.

In vitro permeation and in vivo whitening

effect of topical hesperetin microemulsion

delivery system. International Journal of

Pharmaceutics. 2010;388:257–262.

Lin C, Lin H, Chen H, Yu M, Lee M.

Stability and characterisation of

phospholipid-based curcuminencapsulated Microemulsions. Food

Chemistry. 2009;116:923–928.

Wu H, Ramachandran C, Weiner N D,

Roessler B J. Topical transport of

hydrophilic compounds using water-in-oil

nanoemulsions. International Journal of

Pharmaceutics. 2001;220:63–75.

Xu J et al. The preparation of neem oil

microemulsion (Azadirachta indica) and

the comparison of acaricidal time between

neem oil microemulsion and other

formulations in vitro. Veterinary

Parasitology. 2010;169:399–403.

Mei Z, Chen H, Weng T, Yang Y, Yang

X. Solid lipid nanoparticle and

microemulsion for topical delivery of

triptolide. European Journal of

Pharmaceutics and Biopharmaceutics.

;56:189–196.

Downloads

Published

2011-06-30

How to Cite

Ranjit Kumar Harwansh, Kartik Ch. Patra, & Surendra K. Pareta. (2011). Nanoemulsion as potential vehicles for transdermal delivery of pure phytopharmaceuticals and poorly soluble drug. International Journal of Drug Delivery, 3(2), 209–218. Retrieved from https://ijdd.arjournals.org/index.php/ijdd/article/view/70

Issue

Section

Review Article